eli lilly & co s tirzepatide Lilly's is off the FDA's drug shortage list: Here's what it means eli lilly tirzepatide fda approval

The Congressional Budget Office (CBO) has stated, "The developing market for [anti-obesity medications] could significantly affect health care spending and the federal budget." They contend that passage of the Treat and Reduce Obesity Act would increase costs for anti-obesity medications (i.e., because more people would use them) but reduce federal costs for other related health issues

How does sustained use affect bone mineral density and lean mass over years rather than months

Some benefits can include red blood cell formation and nerve cell health

big pharma and large telehealth marketplaces cant build huge margins around it, so you rarely see splashy campaigns

prausnitzii populations by up to 34%